Stock Taper

Pricing Sign Up Log In

OZEM

Roundhill Investments - GLP-1 & Weight Loss ETF

OZEM

Roundhill Investments - GLP-1 & Weight Loss ETF • Roundhill Investments

$31.76 ▲ 0.67% (+0.21)

Managing Company Roundhill Investments

Asset Under Management $50.15M

Inception Date May 21, 2024

Expense Ratio 0.59%

52w High $37.15

52w Low $23.22

Volume 14,476

Avg Volume 21,601

Asset Class Thematic

About Roundhill Investments - GLP-1 & Weight Loss ETF

Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.

Managing Company Roundhill Investments

Asset Under Management $50.15M

Inception Date May 21, 2024

Expense Ratio 0.59%

52w High $37.15

52w Low $23.22

Volume 14,476

Avg Volume 21,601

Asset Class Thematic

About Roundhill Investments - GLP-1 & Weight Loss ETF

Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.

HOLDINGS (Top 20)

Stock	Name	Weight	Shares	Market Value
LLY	Eli Lilly and Company	18.17%	8.25K	$9.11M
NVO	Novo Nordisk A/S	13.13%	144.43K	$6.58M
PFE	Pfizer Inc.	6.40%	122.60K	$3.21M
VKTX	Viking Therapeutics, Inc.	4.80%	73.54K	$2.41M
KLRA	Kailera Therapeutics, Inc.	4.44%	96.98K	$2.22M
AMGN	Amgen Inc.	3.54%	5.27K	$1.77M
AZN	AstraZeneca PLC	3.29%	8.88K	$1.65M
GPCR	Structure Therapeutics Inc.	2.57%	32.72K	$1.29M
REGN	Regeneron Pharmaceuticals, Inc.	2.45%	2.00K	$1.23M
MBX	MBX Biosciences, Inc. Common Stock	2.06%	32.77K	$1.03M
BHVN	Biohaven Ltd.	1.81%	82.41K	$907.32K
GILD	Gilead Sciences, Inc.	1.71%	6.38K	$857.13K
RYTM	Rhythm Pharmaceuticals, Inc.	1.48%	8.39K	$741.36K
WVE	Wave Life Sciences Ltd.	0.78%	59.42K	$391.02K
CRBP	Corbus Pharmaceuticals Holdings, Inc.	0.24%	15.31K	$121.08K

SECTOR HOLDINGS

Healthcare

Healthcare

100.00%

ASSET ALLOCATION BY REGION

United States

49.20%

Denmark

19.40%

China

12.17%

Japan

5.58%

South Korea

3.66%

United Kingdom

3.45%

Switzerland

2.93%

Hong Kong

2.47%

Singapore

0.78%

Other

0.36%

SECTOR HOLDINGS

Healthcare

Healthcare

100.00%

ASSET ALLOCATION BY REGION

United States

49.20%

Denmark

19.40%

China

12.17%

Japan

5.58%

South Korea

3.66%

United Kingdom

3.45%

Switzerland

2.93%

Hong Kong

2.47%

Singapore

0.78%

Other

0.36%

Holdings (Top 20)

LLY

LLY

Eli Lilly and Company

Weight: 18.17% Shares: 8.25K Value: $9.11M

NVO

NVO

Novo Nordisk A/S

Weight: 13.13% Shares: 144.43K Value: $6.58M

PFE

PFE

Pfizer Inc.

Weight: 6.40% Shares: 122.60K Value: $3.21M

VKTX

VKTX

Viking Therapeutics, Inc.

Weight: 4.80% Shares: 73.54K Value: $2.41M

KLRA

KLRA

Kailera Therapeutics, Inc.

Weight: 4.44% Shares: 96.98K Value: $2.22M

AMGN

AMGN

Amgen Inc.

Weight: 3.54% Shares: 5.27K Value: $1.77M

AZN

AZN

AstraZeneca PLC

Weight: 3.29% Shares: 8.88K Value: $1.65M

GPCR

GPCR

Structure Therapeutics Inc.

Weight: 2.57% Shares: 32.72K Value: $1.29M

REGN

REGN

Regeneron Pharmaceuticals, Inc.

Weight: 2.45% Shares: 2.00K Value: $1.23M

MBX

MBX

MBX Biosciences, Inc. Common Stock

Weight: 2.06% Shares: 32.77K Value: $1.03M

BHVN

BHVN

Biohaven Ltd.

Weight: 1.81% Shares: 82.41K Value: $907.32K

GILD

GILD

Gilead Sciences, Inc.

Weight: 1.71% Shares: 6.38K Value: $857.13K

RYTM

RYTM

Rhythm Pharmaceuticals, Inc.

Weight: 1.48% Shares: 8.39K Value: $741.36K

WVE

WVE

Wave Life Sciences Ltd.

Weight: 0.78% Shares: 59.42K Value: $391.02K

CRBP

CRBP

Corbus Pharmaceuticals Holdings, Inc.

Weight: 0.24% Shares: 15.31K Value: $121.08K